TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells

  1. Díaz-Rodríguez, E.
  2. Pérez-Peña, J.
  3. Ríos-Luci, C.
  4. Arribas, J.
  5. Ocaña, A.
  6. Pandiella, A.
Aldizkaria:
Cancer Letters

ISSN: 1872-7980,  0304-3835

Argitalpen urtea: 2019

Alea: 453

Orrialdeak: 34-44

Mota: Artikulua

DOI: 10.1016/J.CANLET.2019.03.042 GOOGLE SCHOLAR